Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. (ENDV) Stock Competitors & Peer Comparison
See (ENDV) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ENDV | $0.00 | +9900.00% | 15.9K | -0.01 | -$0.01 | N/A |
| NONOF | $46.02 | +2.95% | 205.2B | 12.79 | $3.61 | +3.93% |
| CSLLY | $22.73 | +1.56% | 88B | 14.76 | $1.54 | +3.19% |
| UCBJF | $279.96 | -0.17% | 54.3B | 30.25 | $9.42 | +0.61% |
| UCBJY | $138.32 | +2.61% | 52.7B | 29.37 | $4.71 | +0.61% |
| ARGNF | $803.19 | +10.85% | 49.7B | 41.06 | $19.56 | N/A |
| CMXHF | $90.00 | -1.25% | 43.7B | 14.59 | $6.17 | +3.24% |
| IVBXF | $11.45 | +2.05% | 19.9B | 163.57 | $0.07 | N/A |
| WXXWY | $8.50 | -1.05% | 17.5B | 24.97 | $0.34 | N/A |
| GNMSF | $275.00 | +1.85% | 16.9B | 17.89 | $15.37 | N/A |
Stock Comparison
ENDV vs NONOF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, NONOF has a market cap of 205.2B. Regarding current trading prices, ENDV is priced at $0.00, while NONOF trades at $46.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas NONOF's P/E ratio is 12.79. In terms of profitability, ENDV's ROE is +0.06%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, ENDV is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check NONOF's competition here
ENDV vs CSLLY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CSLLY has a market cap of 88B. Regarding current trading prices, ENDV is priced at $0.00, while CSLLY trades at $22.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CSLLY's P/E ratio is 14.76. In terms of profitability, ENDV's ROE is +0.06%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, ENDV is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CSLLY's competition here
ENDV vs UCBJF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, UCBJF has a market cap of 54.3B. Regarding current trading prices, ENDV is priced at $0.00, while UCBJF trades at $279.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas UCBJF's P/E ratio is 30.25. In terms of profitability, ENDV's ROE is +0.06%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, ENDV is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check UCBJF's competition here
ENDV vs UCBJY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, UCBJY has a market cap of 52.7B. Regarding current trading prices, ENDV is priced at $0.00, while UCBJY trades at $138.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas UCBJY's P/E ratio is 29.37. In terms of profitability, ENDV's ROE is +0.06%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, ENDV is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check UCBJY's competition here
ENDV vs ARGNF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ARGNF has a market cap of 49.7B. Regarding current trading prices, ENDV is priced at $0.00, while ARGNF trades at $803.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ARGNF's P/E ratio is 41.06. In terms of profitability, ENDV's ROE is +0.06%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, ENDV and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
ENDV vs CMXHF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CMXHF has a market cap of 43.7B. Regarding current trading prices, ENDV is priced at $0.00, while CMXHF trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CMXHF's P/E ratio is 14.59. In terms of profitability, ENDV's ROE is +0.06%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, ENDV is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CMXHF's competition here
ENDV vs IVBXF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, IVBXF has a market cap of 19.9B. Regarding current trading prices, ENDV is priced at $0.00, while IVBXF trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas IVBXF's P/E ratio is 163.57. In terms of profitability, ENDV's ROE is +0.06%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, ENDV and IVBXF have similar daily volatility (0.00).Check IVBXF's competition here
ENDV vs WXXWY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, WXXWY has a market cap of 17.5B. Regarding current trading prices, ENDV is priced at $0.00, while WXXWY trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas WXXWY's P/E ratio is 24.97. In terms of profitability, ENDV's ROE is +0.06%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, ENDV is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check WXXWY's competition here
ENDV vs GNMSF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, GNMSF has a market cap of 16.9B. Regarding current trading prices, ENDV is priced at $0.00, while GNMSF trades at $275.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas GNMSF's P/E ratio is 17.89. In terms of profitability, ENDV's ROE is +0.06%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, ENDV is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check GNMSF's competition here
ENDV vs WXIBF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, WXIBF has a market cap of 16.7B. Regarding current trading prices, ENDV is priced at $0.00, while WXIBF trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas WXIBF's P/E ratio is 23.82. In terms of profitability, ENDV's ROE is +0.06%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, ENDV is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check WXIBF's competition here
ENDV vs SBHMY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SBHMY has a market cap of 12.8B. Regarding current trading prices, ENDV is priced at $0.00, while SBHMY trades at $14.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SBHMY's P/E ratio is 37.59. In terms of profitability, ENDV's ROE is +0.06%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ENDV is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check SBHMY's competition here
ENDV vs SBMFF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SBMFF has a market cap of 12.4B. Regarding current trading prices, ENDV is priced at $0.00, while SBMFF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SBMFF's P/E ratio is 23.20. In terms of profitability, ENDV's ROE is +0.06%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ENDV and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
ENDV vs BRRGF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, ENDV is priced at $0.00, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, ENDV's ROE is +0.06%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, ENDV is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check BRRGF's competition here
ENDV vs AAVXF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, ENDV is priced at $0.00, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, ENDV's ROE is +0.06%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, ENDV and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
ENDV vs ODTC Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, ENDV is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ODTC's P/E ratio is 1.07. In terms of profitability, ENDV's ROE is +0.06%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ENDV and ODTC have similar daily volatility (0.00).Check ODTC's competition here
ENDV vs AKBLF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, AKBLF has a market cap of 7.2B. Regarding current trading prices, ENDV is priced at $0.00, while AKBLF trades at $35.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas AKBLF's P/E ratio is 39.07. In terms of profitability, ENDV's ROE is +0.06%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, ENDV is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check AKBLF's competition here
ENDV vs TRSBF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, TRSBF has a market cap of 6.9B. Regarding current trading prices, ENDV is priced at $0.00, while TRSBF trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas TRSBF's P/E ratio is 5.50. In terms of profitability, ENDV's ROE is +0.06%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, ENDV is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check TRSBF's competition here
ENDV vs REGMF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, ENDV is priced at $0.00, while REGMF trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas REGMF's P/E ratio is 57.63. In terms of profitability, ENDV's ROE is +0.06%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, ENDV is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check REGMF's competition here
ENDV vs ABCZF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ENDV is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ENDV's ROE is +0.06%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, ENDV and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
ENDV vs LABFF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ENDV is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ENDV's ROE is +0.06%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, ENDV and LABFF have similar daily volatility (0.00).Check LABFF's competition here
ENDV vs SHJBF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, ENDV is priced at $0.00, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, ENDV's ROE is +0.06%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, ENDV is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check SHJBF's competition here
ENDV vs CAMRF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CAMRF has a market cap of 3.8B. Regarding current trading prices, ENDV is priced at $0.00, while CAMRF trades at $63.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CAMRF's P/E ratio is 47.95. In terms of profitability, ENDV's ROE is +0.06%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, ENDV is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CAMRF's competition here
ENDV vs GNNSF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, GNNSF has a market cap of 3.8B. Regarding current trading prices, ENDV is priced at $0.00, while GNNSF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas GNNSF's P/E ratio is -6.90. In terms of profitability, ENDV's ROE is +0.06%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, ENDV is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check GNNSF's competition here
ENDV vs TLPPF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, TLPPF has a market cap of 3.8B. Regarding current trading prices, ENDV is priced at $0.00, while TLPPF trades at $11.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas TLPPF's P/E ratio is -555.16. In terms of profitability, ENDV's ROE is +0.06%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, ENDV is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check TLPPF's competition here
ENDV vs ZLDPF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ZLDPF has a market cap of 3.4B. Regarding current trading prices, ENDV is priced at $0.00, while ZLDPF trades at $48.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ZLDPF's P/E ratio is 3.45. In terms of profitability, ENDV's ROE is +0.06%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, ENDV and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
ENDV vs ASPHF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, ENDV is priced at $0.00, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, ENDV's ROE is +0.06%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, ENDV and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
ENDV vs BRCTF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, ENDV is priced at $0.00, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BRCTF's P/E ratio is 26.63. In terms of profitability, ENDV's ROE is +0.06%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, ENDV is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check BRCTF's competition here
ENDV vs MPSYF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ENDV is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ENDV's ROE is +0.06%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, ENDV is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check MPSYF's competition here
ENDV vs BVNKF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, ENDV is priced at $0.00, while BVNKF trades at $30.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BVNKF's P/E ratio is 11.02. In terms of profitability, ENDV's ROE is +0.06%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, ENDV is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check BVNKF's competition here
ENDV vs INCPF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, ENDV is priced at $0.00, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas INCPF's P/E ratio is 25.83. In terms of profitability, ENDV's ROE is +0.06%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, ENDV is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check INCPF's competition here
ENDV vs BVNRY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, ENDV is priced at $0.00, while BVNRY trades at $9.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BVNRY's P/E ratio is 10.62. In terms of profitability, ENDV's ROE is +0.06%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, ENDV is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check BVNRY's competition here
ENDV vs ASCLF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ASCLF has a market cap of 2.3B. Regarding current trading prices, ENDV is priced at $0.00, while ASCLF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ASCLF's P/E ratio is -42.84. In terms of profitability, ENDV's ROE is +0.06%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, ENDV is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check ASCLF's competition here
ENDV vs MEOBF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, ENDV is priced at $0.00, while MEOBF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, ENDV's ROE is +0.06%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, ENDV and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
ENDV vs GENSF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, GENSF has a market cap of 2.1B. Regarding current trading prices, ENDV is priced at $0.00, while GENSF trades at $31.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas GENSF's P/E ratio is 32.81. In terms of profitability, ENDV's ROE is +0.06%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, ENDV and GENSF have similar daily volatility (0.00).Check GENSF's competition here
ENDV vs GLPGF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, ENDV is priced at $0.00, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, ENDV's ROE is +0.06%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, ENDV and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
ENDV vs PHMMF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, ENDV is priced at $0.00, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, ENDV's ROE is +0.06%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, ENDV and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
ENDV vs CSPHF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CSPHF has a market cap of 1.6B. Regarding current trading prices, ENDV is priced at $0.00, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, ENDV's ROE is +0.06%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, ENDV is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CSPHF's competition here
ENDV vs BIESF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ENDV is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ENDV's ROE is +0.06%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, ENDV and BIESF have similar daily volatility (0.00).Check BIESF's competition here
ENDV vs ONTTF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ONTTF has a market cap of 1.5B. Regarding current trading prices, ENDV is priced at $0.00, while ONTTF trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ONTTF's P/E ratio is -7.90. In terms of profitability, ENDV's ROE is +0.06%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, ENDV and ONTTF have similar daily volatility (0.00).Check ONTTF's competition here
ENDV vs HBMHF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, ENDV is priced at $0.00, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas HBMHF's P/E ratio is 13.00. In terms of profitability, ENDV's ROE is +0.06%, compared to HBMHF's ROE of +0.28%. Regarding short-term risk, ENDV is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check HBMHF's competition here
ENDV vs SNBIF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, ENDV is priced at $0.00, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, ENDV's ROE is +0.06%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, ENDV is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check SNBIF's competition here
ENDV vs MDCLF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, ENDV is priced at $0.00, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, ENDV's ROE is +0.06%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, ENDV and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
ENDV vs PHGUF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, ENDV is priced at $0.00, while PHGUF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas PHGUF's P/E ratio is -163.50. In terms of profitability, ENDV's ROE is +0.06%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, ENDV is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check PHGUF's competition here
ENDV vs NURPF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, ENDV is priced at $0.00, while NURPF trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas NURPF's P/E ratio is 51.91. In terms of profitability, ENDV's ROE is +0.06%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, ENDV is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check NURPF's competition here
ENDV vs IDRSF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, ENDV is priced at $0.00, while IDRSF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas IDRSF's P/E ratio is -3.30. In terms of profitability, ENDV's ROE is +0.06%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, ENDV is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check IDRSF's competition here
ENDV vs CSBTF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CSBTF has a market cap of 989.2M. Regarding current trading prices, ENDV is priced at $0.00, while CSBTF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CSBTF's P/E ratio is 315.00. In terms of profitability, ENDV's ROE is +0.06%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, ENDV is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CSBTF's competition here
ENDV vs PPTDF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, PPTDF has a market cap of 980.7M. Regarding current trading prices, ENDV is priced at $0.00, while PPTDF trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas PPTDF's P/E ratio is -42.17. In terms of profitability, ENDV's ROE is +0.06%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, ENDV and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
ENDV vs BTTAY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, ENDV is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ENDV's ROE is +0.06%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, ENDV is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check BTTAY's competition here
ENDV vs TKBIF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, ENDV is priced at $0.00, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas TKBIF's P/E ratio is -21.47. In terms of profitability, ENDV's ROE is +0.06%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ENDV is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check TKBIF's competition here
ENDV vs BPMUF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BPMUF has a market cap of 846.9M. Regarding current trading prices, ENDV is priced at $0.00, while BPMUF trades at $69.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BPMUF's P/E ratio is 9.69. In terms of profitability, ENDV's ROE is +0.06%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, ENDV and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
ENDV vs IVEVF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, IVEVF has a market cap of 741.2M. Regarding current trading prices, ENDV is priced at $0.00, while IVEVF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas IVEVF's P/E ratio is -2.39. In terms of profitability, ENDV's ROE is +0.06%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, ENDV is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check IVEVF's competition here
ENDV vs VBIZF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, VBIZF has a market cap of 725M. Regarding current trading prices, ENDV is priced at $0.00, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, ENDV's ROE is +0.06%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, ENDV is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check VBIZF's competition here
ENDV vs SOLTF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SOLTF has a market cap of 605.4M. Regarding current trading prices, ENDV is priced at $0.00, while SOLTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SOLTF's P/E ratio is -7.69. In terms of profitability, ENDV's ROE is +0.06%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, ENDV is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check SOLTF's competition here
ENDV vs CKDXF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, ENDV is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ENDV's ROE is +0.06%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, ENDV is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CKDXF's competition here
ENDV vs GNFTF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, GNFTF has a market cap of 474.3M. Regarding current trading prices, ENDV is priced at $0.00, while GNFTF trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas GNFTF's P/E ratio is -4.69. In terms of profitability, ENDV's ROE is +0.06%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, ENDV is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check GNFTF's competition here
ENDV vs RAONF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, ENDV is priced at $0.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas RAONF's P/E ratio is -43.33. In terms of profitability, ENDV's ROE is +0.06%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, ENDV is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check RAONF's competition here
ENDV vs GNFTY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, ENDV is priced at $0.00, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, ENDV's ROE is +0.06%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, ENDV is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check GNFTY's competition here
ENDV vs TBGNF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ENDV is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ENDV's ROE is +0.06%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, ENDV and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
ENDV vs CYDY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CYDY has a market cap of 433.7M. Regarding current trading prices, ENDV is priced at $0.00, while CYDY trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CYDY's P/E ratio is -7.94. In terms of profitability, ENDV's ROE is +0.06%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, ENDV is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CYDY's competition here
ENDV vs INRLF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, INRLF has a market cap of 430.2M. Regarding current trading prices, ENDV is priced at $0.00, while INRLF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas INRLF's P/E ratio is -3.12. In terms of profitability, ENDV's ROE is +0.06%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, ENDV and INRLF have similar daily volatility (0.00).Check INRLF's competition here
ENDV vs AVCTF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, AVCTF has a market cap of 425M. Regarding current trading prices, ENDV is priced at $0.00, while AVCTF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas AVCTF's P/E ratio is -6.48. In terms of profitability, ENDV's ROE is +0.06%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, ENDV is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check AVCTF's competition here
ENDV vs PTCHF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, PTCHF has a market cap of 411.4M. Regarding current trading prices, ENDV is priced at $0.00, while PTCHF trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas PTCHF's P/E ratio is -3.67. In terms of profitability, ENDV's ROE is +0.06%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, ENDV and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
ENDV vs NWPHF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, ENDV is priced at $0.00, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ENDV's ROE is +0.06%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, ENDV is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check NWPHF's competition here
ENDV vs CLVLY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CLVLY has a market cap of 355.9M. Regarding current trading prices, ENDV is priced at $0.00, while CLVLY trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CLVLY's P/E ratio is 15.35. In terms of profitability, ENDV's ROE is +0.06%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, ENDV is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CLVLY's competition here
ENDV vs NWBO Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, NWBO has a market cap of 342.1M. Regarding current trading prices, ENDV is priced at $0.00, while NWBO trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas NWBO's P/E ratio is -5.32. In terms of profitability, ENDV's ROE is +0.06%, compared to NWBO's ROE of +0.71%. Regarding short-term risk, ENDV is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check NWBO's competition here
ENDV vs SLNCF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SLNCF has a market cap of 334.4M. Regarding current trading prices, ENDV is priced at $0.00, while SLNCF trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SLNCF's P/E ratio is -3.75. In terms of profitability, ENDV's ROE is +0.06%, compared to SLNCF's ROE of -3.59%. Regarding short-term risk, ENDV and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
ENDV vs CLVLF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CLVLF has a market cap of 332.7M. Regarding current trading prices, ENDV is priced at $0.00, while CLVLF trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CLVLF's P/E ratio is 14.35. In terms of profitability, ENDV's ROE is +0.06%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, ENDV and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
ENDV vs SPHDF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SPHDF has a market cap of 330.6M. Regarding current trading prices, ENDV is priced at $0.00, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SPHDF's P/E ratio is -4.85. In terms of profitability, ENDV's ROE is +0.06%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, ENDV is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check SPHDF's competition here
ENDV vs NGENF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, ENDV is priced at $0.00, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas NGENF's P/E ratio is -15.19. In terms of profitability, ENDV's ROE is +0.06%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, ENDV is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check NGENF's competition here
ENDV vs FGHQF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, ENDV is priced at $0.00, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, ENDV's ROE is +0.06%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, ENDV and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
ENDV vs PBBIF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ENDV is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ENDV's ROE is +0.06%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ENDV and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
ENDV vs ORPOF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, ENDV is priced at $0.00, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, ENDV's ROE is +0.06%, compared to ORPOF's ROE of N/A. Regarding short-term risk, ENDV and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
ENDV vs ORYZF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, ENDV is priced at $0.00, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, ENDV's ROE is +0.06%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, ENDV is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check ORYZF's competition here
ENDV vs HNSBF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, ENDV is priced at $0.00, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas HNSBF's P/E ratio is -3.37. In terms of profitability, ENDV's ROE is +0.06%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, ENDV is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check HNSBF's competition here
ENDV vs HLOSF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, HLOSF has a market cap of 236.9M. Regarding current trading prices, ENDV is priced at $0.00, while HLOSF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas HLOSF's P/E ratio is -12.94. In terms of profitability, ENDV's ROE is +0.06%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, ENDV is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check HLOSF's competition here
ENDV vs SCNLF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SCNLF has a market cap of 236.6M. Regarding current trading prices, ENDV is priced at $0.00, while SCNLF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SCNLF's P/E ratio is -22.80. In terms of profitability, ENDV's ROE is +0.06%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, ENDV and SCNLF have similar daily volatility (0.00).Check SCNLF's competition here
ENDV vs SPHRY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SPHRY has a market cap of 223.1M. Regarding current trading prices, ENDV is priced at $0.00, while SPHRY trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SPHRY's P/E ratio is -88.33. In terms of profitability, ENDV's ROE is +0.06%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, ENDV is less volatile compared to SPHRY. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check SPHRY's competition here
ENDV vs CMVLF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, ENDV is priced at $0.00, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, ENDV's ROE is +0.06%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, ENDV and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
ENDV vs SPHRF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, SPHRF has a market cap of 218.9M. Regarding current trading prices, ENDV is priced at $0.00, while SPHRF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas SPHRF's P/E ratio is -52.00. In terms of profitability, ENDV's ROE is +0.06%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, ENDV is less volatile compared to SPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check SPHRF's competition here
ENDV vs CAIHF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, ENDV is priced at $0.00, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, ENDV's ROE is +0.06%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, ENDV is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check CAIHF's competition here
ENDV vs BOVNF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, ENDV is priced at $0.00, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, ENDV's ROE is +0.06%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, ENDV is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check BOVNF's competition here
ENDV vs FPHAF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ENDV is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ENDV's ROE is +0.06%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, ENDV and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
ENDV vs KNTPF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, KNTPF has a market cap of 193.1M. Regarding current trading prices, ENDV is priced at $0.00, while KNTPF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas KNTPF's P/E ratio is -6.86. In terms of profitability, ENDV's ROE is +0.06%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, ENDV is less volatile compared to KNTPF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check KNTPF's competition here
ENDV vs ADOCY Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, ENDV is priced at $0.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ENDV's ROE is +0.06%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, ENDV and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
ENDV vs BBIXF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, ENDV is priced at $0.00, while BBIXF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, ENDV's ROE is +0.06%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, ENDV is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check BBIXF's competition here
ENDV vs AMGXF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, ENDV is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ENDV's ROE is +0.06%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, ENDV is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check AMGXF's competition here
ENDV vs IPHYF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, IPHYF has a market cap of 140.7M. Regarding current trading prices, ENDV is priced at $0.00, while IPHYF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas IPHYF's P/E ratio is -2.34. In terms of profitability, ENDV's ROE is +0.06%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, ENDV and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
ENDV vs BRIBF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, ENDV is priced at $0.00, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, ENDV's ROE is +0.06%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, ENDV is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check BRIBF's competition here
ENDV vs HBPCF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, ENDV is priced at $0.00, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, ENDV's ROE is +0.06%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, ENDV and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
ENDV vs AAPGV Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ENDV is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ENDV's ROE is +0.06%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, ENDV is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check AAPGV's competition here
ENDV vs TRGNF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, ENDV is priced at $0.00, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas TRGNF's P/E ratio is -2.58. In terms of profitability, ENDV's ROE is +0.06%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, ENDV and TRGNF have similar daily volatility (0.00).Check TRGNF's competition here
ENDV vs PSTTF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ENDV is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ENDV's ROE is +0.06%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ENDV and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
ENDV vs JWCTF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, JWCTF has a market cap of 116.6M. Regarding current trading prices, ENDV is priced at $0.00, while JWCTF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, ENDV's ROE is +0.06%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, ENDV is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check JWCTF's competition here
ENDV vs EPRXF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ENDV is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ENDV's ROE is +0.06%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, ENDV is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check EPRXF's competition here
ENDV vs ADOIF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, ENDV is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ENDV's ROE is +0.06%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ENDV and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
ENDV vs MSCLF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, ENDV is priced at $0.00, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, ENDV's ROE is +0.06%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, ENDV is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check MSCLF's competition here
ENDV vs MLLCF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, MLLCF has a market cap of 95.4M. Regarding current trading prices, ENDV is priced at $0.00, while MLLCF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas MLLCF's P/E ratio is -1.22. In terms of profitability, ENDV's ROE is +0.06%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, ENDV and MLLCF have similar daily volatility (0.00).Check MLLCF's competition here
ENDV vs NDTP Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, NDTP has a market cap of 92.8M. Regarding current trading prices, ENDV is priced at $0.00, while NDTP trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas NDTP's P/E ratio is -2.90. In terms of profitability, ENDV's ROE is +0.06%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, ENDV and NDTP have similar daily volatility (0.00).Check NDTP's competition here
ENDV vs MCURF Comparison May 2026
ENDV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENDV stands at 15.9K. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, ENDV is priced at $0.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENDV currently has a P/E ratio of -0.01, whereas MCURF's P/E ratio is -16.90. In terms of profitability, ENDV's ROE is +0.06%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, ENDV is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for ENDV.Check MCURF's competition here